FDA updates labeling for CARBAMAZEPINE FDA Approval Jan. 06, 2026, 09:50 UTC Labeling changes approved for AMNEAL PHARMS. Active ingredient: CARBAMAZEPINE. Decision date: 01/05/2026 Full text
There are no comments here yet...